Keywords: ahp, still, pursued, fen-phen, specter, having, settled
AHP still pursued by fen-phen specter
Article | 11 September 2001
Having settled numerous lawsuits in the USA regarding the diet drugsPondimin (fenfluramine) and Redux (dexfenfluramine; Marketletters passim), any hopes American ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- InSite Vision joins Merck & Co and Pfizer in patent infringement law suit against
- Osteoporosis drug bazedoxifene stops growth of breast cancer cells, even in resistant tumors
- Highlights of EHA meeting: Novartis' Jakavi; Bristol-Myers and AbbVie's elotuzumab; Janssen's ibrutinib
- Additional indications in Japan for Roche's Avastin and Astellas' Prograf
- US Supreme Court says patent settlement can "sometimes" be illegal
